The consensus for Avolta is composed of the following analysts, who provide institutional investors with research findings and reports:
Analyst Coverage & Consensus
Avolta's coverage by sell-side analysts
-
Barclays
-
Berengberg Bank
Analyst
Benjamin Sandland-Taylor
Phone
Email
-
Deutsche Bank
-
Exane BNP Paribas
-
Goldman Sachs
-
HSBC
-
JP Morgan
-
Kepler Cheuvreux
-
Mediobanca
-
Morgan Stanley
-
MORGAN STANLEY
-
Octavian
-
Oddo
-
RBC Capital Markets
-
Research Partners
-
Santander
-
UBS
-
Vontobel
-
Zürcher Kantonalbank
Consensus
Gathered by VARA Research

Consensus as of February 27, 2025
This consensus has been issued by Vara Research GmbH for information purposes only and is not intended to constitute investment advice. It is based on estimates and forecasts of various analysts regarding revenues, earnings and business developments of the relevant company. The company did not participate in the compilation of the estimates and it does not endorse them. Such estimates and forecasts cannot be independently verified by reason of the subjective character. Vara Research GmbH gives no guarantee, representation or warranty and is not responsible or liable as to its accuracy and completeness.
Consensus data are calculated as a median.
Avolta Number of Shares
Avolta expects for full-year 2023 a weighted average number of shares outstanding of 137.5 million (diluted).
For year-end 2023 (31/12/2023), Avolta expects a total number of shares outstanding of 152.6 million (diluted).
Related Information
These sections might also be of interest to you: